FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2883368518> ?p ?o ?g. }

• W2883368518 endingPage "S903" @default.
• W2883368518 startingPage "S903" @default.
• W2883368518 abstract "Background We analyzed the outcomes of ABO compatible and DSA positive living donor liver transplantation (LDLT) focusing on preformed or de novo donor specific anti-HLA antibody (DSA). Patients and Methods We have decided immunosuppression protocol including portal infusion (PI) therapy depending on the results of lymphocyte cytotoxicity test (LCT) and ABO incompatibility. In all cases, we employed 3 drugs (CNI, antimetabolite, and steroid) for systemic immunosuppression. In ABO compatible and LCT negative cases, we used PGE1 for PI therapy. In ABO compatible and LCT positive cases, we used PGE1 and gabexate mesylate for PI therapy. In ABO incompatible (ABOI) cases, we used 3 drugs (PGE1, gabexate mesylate, and steroid) for PI therapy in addition to plasma exchange and rituximab. We investigated following 2 issues. I) Preformed DSA: Twenty-five recipients whose anti-HLA antibody test (screening test, PRA) was examined were divided into 4 groups depending on the result of (PRA and ABO incompatible (ABOI))=(-, -), (+, -), (-, +), (+, +), and 6-month survival was assessed in each group. In the group of (+, -), anti-HLA antibody test (single antigen test, Luminex) was performed and preformed DSA positive recipients were identified. II) De novo DSA: In the 273 LDLTs, recipients who developed antibody mediated rejection (AMR) were retrospectively identified and the outcomes were assessed. Results I) Six-month survivals were 62, 81, 100, 100% in (-, -), (+, -), (-, +), and (+, +), respectively. Out of the 9 patients in (+, -), 4 recipients were strongly positive for preformed DSA (>10,000MFI). All 4 recipients were adult female. There were 3 cases of PBC and 1 case of hepatitis C. All of them postoperatively received immunosuppression including PI therapy and their postoperative courses were uneventful. None of them developed AMR. II) Four recipients were identified to have developed AMR postoperatively. Two of them (cases 1 and 2) developed AMR in 2008 and 2010 and DSA was not determined in these years, but their pre and postoperative results of LCT suggested that de novo DSA appeared. Two of them (cases 3 and 4) developed AMR in 2015 and 2016 and DSA was negetive preoperatively but became strongly positive postoperatively. Three (cases 1 to 3) died of AMR and 1 (case 4) survived after re-transplantation. Three (cases 1, 3, and 4) did not receive PI therapy because of individual reasons. Conclusion Outcomes of recipients who had preformed DSA was satisfactory but those of recipients who developed do novo DSA was poor. Our immunosuppression protocol including PI therapy may be associated with the outcomes." @default.
• W2883368518 created "2018-08-03" @default.
• W2883368518 creator A5003537923 @default.
• W2883368518 creator A5010973453 @default.
• W2883368518 creator A5013182907 @default.
• W2883368518 creator A5013331706 @default.
• W2883368518 creator A5014273795 @default.
• W2883368518 creator A5014718861 @default.
• W2883368518 creator A5018112691 @default.
• W2883368518 creator A5044663343 @default.
• W2883368518 creator A5046859907 @default.
• W2883368518 creator A5063445703 @default.
• W2883368518 creator A5080475278 @default.
• W2883368518 creator A5082561795 @default.
• W2883368518 creator A5084039755 @default.
• W2883368518 creator A5084693578 @default.
• W2883368518 creator A5084805424 @default.
• W2883368518 creator A5087264886 @default.
• W2883368518 creator A5088954739 @default.
• W2883368518 date "2018-07-01" @default.
• W2883368518 modified "2023-10-18" @default.
• W2883368518 title "Outcomes of ABO Compatible and DSA Positive Living Donor Liver Transplantation" @default.
• W2883368518 doi "https://doi.org/10.1097/01.tp.0000544004.57826.ec" @default.
• W2883368518 hasPublicationYear "2018" @default.
• W2883368518 type Work @default.
• W2883368518 sameAs 2883368518 @default.
• W2883368518 citedByCount "0" @default.
• W2883368518 crossrefType "journal-article" @default.
• W2883368518 hasAuthorship W2883368518A5003537923 @default.
• W2883368518 hasAuthorship W2883368518A5010973453 @default.
• W2883368518 hasAuthorship W2883368518A5013182907 @default.
• W2883368518 hasAuthorship W2883368518A5013331706 @default.
• W2883368518 hasAuthorship W2883368518A5014273795 @default.
• W2883368518 hasAuthorship W2883368518A5014718861 @default.
• W2883368518 hasAuthorship W2883368518A5018112691 @default.
• W2883368518 hasAuthorship W2883368518A5044663343 @default.
• W2883368518 hasAuthorship W2883368518A5046859907 @default.
• W2883368518 hasAuthorship W2883368518A5063445703 @default.
• W2883368518 hasAuthorship W2883368518A5080475278 @default.
• W2883368518 hasAuthorship W2883368518A5082561795 @default.
• W2883368518 hasAuthorship W2883368518A5084039755 @default.
• W2883368518 hasAuthorship W2883368518A5084693578 @default.
• W2883368518 hasAuthorship W2883368518A5084805424 @default.
• W2883368518 hasAuthorship W2883368518A5087264886 @default.
• W2883368518 hasAuthorship W2883368518A5088954739 @default.
• W2883368518 hasConcept C126322002 @default.
• W2883368518 hasConcept C141071460 @default.
• W2883368518 hasConcept C159654299 @default.
• W2883368518 hasConcept C176080213 @default.
• W2883368518 hasConcept C203014093 @default.
• W2883368518 hasConcept C2779609443 @default.
• W2883368518 hasConcept C2780252810 @default.
• W2883368518 hasConcept C2780653079 @default.
• W2883368518 hasConcept C2911091166 @default.
• W2883368518 hasConcept C71924100 @default.
• W2883368518 hasConcept C90924648 @default.
• W2883368518 hasConceptScore W2883368518C126322002 @default.
• W2883368518 hasConceptScore W2883368518C141071460 @default.
• W2883368518 hasConceptScore W2883368518C159654299 @default.
• W2883368518 hasConceptScore W2883368518C176080213 @default.
• W2883368518 hasConceptScore W2883368518C203014093 @default.
• W2883368518 hasConceptScore W2883368518C2779609443 @default.
• W2883368518 hasConceptScore W2883368518C2780252810 @default.
• W2883368518 hasConceptScore W2883368518C2780653079 @default.
• W2883368518 hasConceptScore W2883368518C2911091166 @default.
• W2883368518 hasConceptScore W2883368518C71924100 @default.
• W2883368518 hasConceptScore W2883368518C90924648 @default.
• W2883368518 hasIssue "Supplement 7" @default.
• W2883368518 hasLocation W28833685181 @default.
• W2883368518 hasOpenAccess W2883368518 @default.
• W2883368518 hasPrimaryLocation W28833685181 @default.
• W2883368518 hasRelatedWork W1964145194 @default.
• W2883368518 hasRelatedWork W1975314410 @default.
• W2883368518 hasRelatedWork W1990798689 @default.
• W2883368518 hasRelatedWork W2004671231 @default.
• W2883368518 hasRelatedWork W2040006709 @default.
• W2883368518 hasRelatedWork W2141769949 @default.
• W2883368518 hasRelatedWork W2151448166 @default.
• W2883368518 hasRelatedWork W2271721100 @default.
• W2883368518 hasRelatedWork W2772213847 @default.
• W2883368518 hasRelatedWork W2790541225 @default.
• W2883368518 hasVolume "102" @default.
• W2883368518 isParatext "false" @default.
• W2883368518 isRetracted "false" @default.
• W2883368518 magId "2883368518" @default.
• W2883368518 workType "article" @default.